Cargando…
Correction to: LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
Autores principales: | Wu, Yue, Wang, Ting, Xia, Lin, Zhang, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464150/ https://www.ncbi.nlm.nih.gov/pubmed/37612733 http://dx.doi.org/10.1186/s12935-023-03029-y |
Ejemplares similares
-
LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
por: Wu, Yue, et al.
Publicado: (2021) -
LncRNA TRPM2-AS promotes ovarian cancer progression and cisplatin resistance by sponging miR-138-5p to release SDC3 mRNA
por: Ding, Yi, et al.
Publicado: (2021) -
LncRNA WDFY3‐AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR‐2355‐5p/SOCS2 axis
por: Zhang, Qing, et al.
Publicado: (2020) -
lncRNA SNHG3 acts as oncogene in ovarian cancer through miR-139-5p and Notch1
por: Zhang, Li, et al.
Publicado: (2021) -
LncRNA SNHG3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-139-5p/MYB axis
por: Xie, Yan, et al.
Publicado: (2021)